ElizabethDianeTateNP

PubMed

• 8 citations
  Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS.
  Michael R. Pranzatelli, Nathan R. McGee, Elizabeth D. Tate> ;Journal of Neuroimmunology. 2018 Aug 15
• 6 citations
  Evaluation of Responsiveness to Reduced-Dose Rituximab in Corticotropin/Intravenous Immunoglobulin/Rituximab Combination Immunotherapy for Opsoclonus-Myoclonus Syndrome.
  Michael R. Pranzatelli, Elizabeth D. Tate, Nathan R. McGee, Craig A. MacArthur> ;Pediatric Neurology. 2018 May 18
• 13 citations
  Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
  Michael R. Pranzatelli, Elizabeth D. Tate, Nathan R. McGee> ;Pediatric Blood & Cancer. 2018 May 4
• Effect of Low-Dose Cyclophosphamide, ACTH, and IVIG Combination Immunotherapy on Neuroinflammation in Pediatric-Onset OMS: A Retrospective Pilot Study
  Michael R Pranzatelli, Elizabeth D Tate> ;European Journal of Paediatric Neurology.
• 3 citations
  Corrigendum to "Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome" [Pediatric Neurology 73...
  Michael R. Pranzatelli, Elizabeth D. Tate> ;Pediatric Neurology. 2018 Jan 1
• Response to Sharawat and Suther.
  Michael R. Pranzatelli, Elizabeth D. Tate> ;Pediatric Neurology. 2018 Jan 1
• 4 citations
  Rituximab, IVIg, and Tetracosactide (ACTH1–24) Combination Immunotherapy (“RITE-CI”) for Pediatric Opsoclonus-Myoclonus Syndrome: Immunomarkers and Clinical Observations
  Michael R. Pranzatelli, Elizabeth D. Tate, Michael Alber, Maha Awadalla, Lubov Blumkin, Elena S. Lina, Steffen Leiz, J. Móser> ;Neuropediatrics. 2017 Dec 19
• 5 citations
  6-Mercaptopurine modifies cerebrospinal fluid T cell abnormalities in paediatric opsoclonus-myoclonus as steroid sparer
  Michael R. Pranzatelli, Elizabeth D. Tate, Tyler J. Allison> ;Clinical and Experimental Immunology. 2017 Jul 15
• 21 citations
  Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome.
  Michael R. Pranzatelli, Elizabeth D. Tate> ;Pediatric Neurology. 2017 Aug 1
• 29 citations
  Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome.
  Elizabeth D. Tate, Michael R. Pranzatelli, Steven Verhulst, Stephen Markwell, David Neal Franz, William D. Graf, S. Anne Joseph, Yasmin Khakoo, Warren D. Lo, Wendy G. ...> ;Journal of Child Neurology. 2012 Feb 28
• Join now to see all